SEOUL, South Korea--(BUSINESS WIRE)--Dong-A Pharmaceutical Co Ltd: CONTRACT WITH OTECHESTVENNYE LEKARSTVA OJSC CALLS FOR MINIMUM EXPORTS OF US$50 MILLION OVER 5 YEARS FOLLOWS US$30 MILLION CONTRACT WITH SAUDI ARABIAN DRUG COMPANY, STP OTECHESVENNYE JSC COMMITS TO AGGRESSIVE MARKETING PROGRAM TO SUPPORT ZYDENA AS A BLOCKBUSTER DRUG Dong-A Pharmaceutical Co Ltd (000640 KS) announced that its subsidiary, Dong-A Pharm-tech, entered into a five-year, US$50 Million contract with Otechestvennye Lekarstva OJSC to market Zydena, Dong-A’s erectile dysfunction drug, in Russia.
